Market Place
Sourcing Support
Biogen Primed to Capture Patients Leaving Lilly`s Kisunla
29 Apr 2026 //
BIOSPACE
With Trial Looming, Biogen And Investors Settle Aduhelm Claims
08 Apr 2026 //
FIERCE PHARMA
Biogen Announces Board Chair Transition
11 Feb 2026 //
GLOBENEWSWIRE
Leqembi® Sales Reach $20.7B In Q4 2025
06 Feb 2026 //
PR NEWSWIRE BIO
Biogen Completes Acquisition Of Alcyone Therapeutics
15 Nov 2025 //
GLOBENEWSWIRE
Sales of Leqembi Totaled 18 Billion Yen in Third Quarter 2025
30 Oct 2025 //
PR NEWSWIRE
Biogen-Backed Web Series Gets Bill Nye Back In The Lab
30 Sep 2025 //
FIERCE PHARMA
Zurzuvae First MHRA-Licensed Therapy for Post-Natal Depression
28 Aug 2025 //
PHARMAWEB
With $2 B Investment, Biogen Will Increase Its Presence in NC
22 Jul 2025 //
FIERCE PHARMA
Biogen Starts Ph3 Omaveloxolone in Pediatric Friedreich Ataxia
18 Jun 2025 //
GLOBENEWSWIRE
Biogen, BMS and Novartis bag spots on Cannes Lions shortlists
16 Jun 2025 //
FIERCE PHARMA
Biogen blueprints headquarters move to new digs in Cambridge
25 Mar 2025 //
FIERCE PHARMA
NICE again rejects Alzheimer`s drugs from Lilly and Biogen/Eisai
07 Mar 2025 //
FIERCE PHARMA
Sage rejects Biogen`s $469 million takeover offer
28 Jan 2025 //
BIOSPACE
Biogen CEO sees no burning need for more acquisitions
15 Jan 2025 //
REUTERS
Private Medicare Plans Must Cover Biogen`s ALS Drug
12 Dec 2024 //
REUTERS
EU backs Eisai-Biogen Alzheimer`s drug after initial rejection
16 Nov 2024 //
REUTERS
5 Reasons Biogen’s Shares Have Dropped 36% in 2024
13 Nov 2024 //
BIOSPACE
Biogen To Present Data At CTAD 2024 Annual Conference
24 Oct 2024 //
GLOBENEWSWIRE
Suboptimal Leqembi vials could create millions in waste
15 Oct 2024 //
FIERCE PHARMA
Biogen And Investors Want US Court To Clarify Class Certification
02 Oct 2024 //
REUTERS
Sage Therapeutics Ends Biogen Collaboration On SAGE-324
26 Sep 2024 //
BUSINESSWIRE
IGC Pharma Advances IGC-AD1 Toward Trials for Alzheimer`s Anti-Amyloid Treatment
04 Sep 2024 //
BUSINESSWIRE
New Alzheimer`s drug deemed too costly for UK`s state-run health service
22 Aug 2024 //
REUTERS
BioArctic Comments On Lecanemab Approval Rumors In Britain
22 Aug 2024 //
PR NEWSWIRE
Incyte`s blood cancer drug succeeds late-stage trial
16 Aug 2024 //
REUTERS
Metagenomi axes ALS program after seeing Biogen and Ionis flounder
14 Aug 2024 //
FIERCE BIOTECH
Biogen Keeps Biosimilars As Leqembi Advances Amid Business Shift
02 Aug 2024 //
FIERCE PHARMA
Last year, Biogen’s CEO said no risky deals. Now, he’s ready to be bold
01 Aug 2024 //
FIERCE BIOTECH
Biogen lifts profit forecast, signals progress in turnaround effort
01 Aug 2024 //
REUTERS
Eisai, Biogen Show Leqembi`s Added Benefits Over Time
31 Jul 2024 //
FIERCE PHARMA
Benefit of Eisai and Biogen`s Alzheimer`s drug increases over time, studies suggest
31 Jul 2024 //
REUTERS
Biogen, Beckman Coulter, Fujirebio Collaborate On Alzheimer`s Biomarkers
30 Jul 2024 //
GLOBENEWSWIRE
Alzheimer`s drug from Eisai and Biogen rejected in Europe
27 Jul 2024 //
REUTERS
Update On EU Regulatory Review Of Lecanemab For Early Alzheimer`s
26 Jul 2024 //
GLOBENEWSWIRE
Biogen, Sage Scrap Essential Tremor Study After Phase II Failure
24 Jul 2024 //
PRESS RELEASE
Lilly Aims For Alzheimer`s Market Leadership Following Kisunla Approval
11 Jul 2024 //
FIERCE PHARMA
Biogen Completes Acquisition of HI-Bio
03 Jul 2024 //
CONTRACT PHARMA
Biogen Completes Acquisition of Human Immunology Biosciences
02 Jul 2024 //
GLOBENEWSWIRE
Japan`s Eisai developing dementia drug for US market, Nikkei reports
01 Jul 2024 //
REUTERS
Eisai and Biogen launch Alzheimer`s drug Leqembi in China
28 Jun 2024 //
REUTERS
Lilly Alzheimer`s drug gets unanimous backing from FDA advisory panel
11 Jun 2024 //
REUTERS
Lilly tipped to beat Eisai, Biogen, win $13B Alzheimer`s fight
07 Jun 2024 //
FIERCE PHARMA
US FDA staff raise no major concerns about Eli Lilly Alzheimer`s drug
07 Jun 2024 //
REUTERS
Novartis, Roche unit and others face Italy antitrust probe over eye drug
07 Jun 2024 //
REUTERS
Biogen, Delta Collaborate On Accessible Air Travel Future
03 Jun 2024 //
GLOBENEWSWIRE
Biogen Acquires Human Immunology For Immunology Portfolio Boost
22 May 2024 //
GLOBENEWSWIRE
Interview with Siddhartha Mukherjee; Tracking Wegovy’s long-term effects
17 May 2024 //
ENDPTS
Biogen, Ionis to discontinue development of experimental ALS drug
17 May 2024 //
REUTERS
Biogen CEO Viehbacher undaunted by Lilly`s impending Alzheimer`s therapy
16 May 2024 //
ENDPTS
Eisai starts rolling submission for inj. version of Alzheimer`s drug US FDA
14 May 2024 //
REUTERS
How Editas `dragged` new CSO over after 37 years at Biogen
10 May 2024 //
FIERCE BIOTECH
C4 Therapeutics Q1 2024 Results, Business Highlights
08 May 2024 //
GLOBENEWSWIRE
US FDA panel to discuss Eli Lilly Alzheimer`s drug on June 10
08 May 2024 //
REUTERS
People with two copies of a risk gene have genetic form of Alzheimer`s, scientists say
07 May 2024 //
REUTERS
Biogen Reports Progress on Corporate Responsibility Priorities
02 May 2024 //
GLOBENEWSWIRE
Biogen plots 30% Leqembi field force bump, omnichannel campaigns
25 Apr 2024 //
FIERCE PHARMA
Biogen cost cuts drive profit beat, as Alzheimer`s drug off to slow start
25 Apr 2024 //
REUTERS
Biogen Q1 2024: 1% GAAP EPS Growth, 8% Non-GAAP EPS Growth
24 Apr 2024 //
PRESS RELEASE
Lilly glides out of Leqembi slipstream with FDA meeting request
17 Apr 2024 //
FIERCE BIOTECH
